On Friday, Shares of Merck & Co. Inc. (NYSE:MRK), gained 0.34% to $59.18.
Merck & Co., known as MSD outside the United States and Canada, and The University of Texas MD Anderson Cancer Center recently declared that they have reached a planned clinical research partnership to evaluate Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel antitumor medicines.
Under the terms of the agreement, collaborative studies will be conducted in the following tumor types: gastroesophageal adenocarcinoma, pancreatic adenocarcinoma, and hepatocellular carcinoma — over the three-year period of the collaboration. The first studies are planned to start enrolling later this year.
The agreement aims to define what combination modalities will work best with KEYTRUDA in these types of tumors by exploring promising new alternatives. The studies will be conducted in parallel, in order to determine optimal regimens in the most efficient manner possible.
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases.
Shares of Fiat Chrysler Automobiles N.V. (NYSE:FCAU), declined -0.32% to $15.59, during its last trading session.
Fiat Chrysler Automobiles is recalling 85,816 Chrysler 200 sedans globally because of an electrical problem that could cause the vehicles to stall, according to AP.
The recall affects certain 2015 Chrysler 200 midsize cars. Almost all were sold in the U.S., but the recall also covers 7,115 cars in Canada, 848 in Mexico and 19 outside North America. AP Reports
Fiat Chrysler says some electrical connectors were damaged when a supplier was conducting post-production tests. The problem could cause the engine to stall or shift the gear unexpectedly to neutral. AP added.
Fiat Chrysler Automobiles N.V., an automotive group, designs, engineers, manufactures, distributes, and sells vehicles and components. It offers passenger cars, light trucks, and light commercial vehicles under the Abarth, Alfa Romeo, Chrysler, Dodge, Fiat, Fiat Professional, Jeep, Lancia, and Ram brand names, in addition to after-sales services and parts under the Mopar brand name.
Finally, Martin Marietta Materials, Inc. (NYSE:MLM), ended its last trade with 1.67% gain, and closed at $175.03, hitting its highest level.
Martin Marietta Materials stated its results for the second quarter ended June 30, 2015.
NOTABLE ITEMS FOR THE QUARTER (ALL COMPARISONS ARE AS COMPARED TO THE PRECEDING-YEAR SECOND QUARTER)
- Merged net sales of $850.2 million contrast with $601.9 million, an enhance of 41%
- Aggregates product line volume enhance of 7.8%; aggregates product line price enhance of 8.5%
- Heritage aggregates product line volume enhance of 0.7%, not taking into account shipments from 2014 divestitures from preceding-year quarter; stated heritage volume decrease of 1.9%
- Heritage aggregates product line price enhance of 7.6%
- Cement business net sales of $100.4 million, gross profit of $30.4 million and EBITDA of $37.8 million
- Magnesia Specialties net sales of $60.5 million and earnings from operations of $18.8 million.
Martin Marietta Materials, Inc., together with its auxiliaries, supplies aggregates products and heavy building materials for the construction industry in the United States and internationally. It operates through Mid-America Group, Southeast Group, West Group, Cement, and Magnesia Specialties segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
